Cumberland PharmaceuticalsCPIX
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 29 institutions reported holding Cumberland Pharmaceuticals (CPIX) in their 13F filings, up 2 from Q4 2025. 7 opened new positions and 6 sold out. The largest holders were Ikarian Capital, LLC ($1.8M), Renaissance Technologies ($1.5M) and Vanguard Capital Management LLC ($1.2M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cumberland Pharmaceuticals
- CUSIP
- 230770109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $310K |
| Exits | 6 | $417K |
All 13F filers, Q4 2025 → Q1 2026: 118,741 shares bought and 310,411 shares sold, net −191,670 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 29 holders
| Ikarian Capital, LLC | 0.26% | Reduce -0.5% | 553,153 | $1.8M |
| Renaissance Technologies | 0.00% | Reduce -0.3% | 470,696 | $1.5M |
| Vanguard Capital Management LLC | 0.00% | — | 361,759 | $1.2M |
| Dimensional Fund Advisors LP | 0.00% | Add +1.5% | 276,359 | $898K |
| Perceptive Advisors LLC | 0.01% | Reduce -42.3% | 196,978 | $640K |
| Bridgeway Capital Management, LLC | 0.01% | No change | 163,468 | $531K |
| Boothbay Fund Management, LLC | 0.01% | Reduce -0.6% | 127,694 | $415K |
| Geode Capital Management, LLC | 0.00% | Add +6.5% | 114,293 | $371K |
| J. Goldman & Co LP | 0.01% | Reduce -14.3% | 81,040 | $263K |
| Bank of New York Mellon Corp | 0.00% | Reduce -19.4% | 58,458 | $190K |
| BlackRock, Inc. | 0.00% | Add +8.2% | 56,891 | $185K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 45,623 | $148K |
| Acadian Asset Management LLC | 0.00% | No change | 44,288 | $143K |
| State Street Corp. | 0.00% | Add +17.2% | 39,510 | $128K |
| Marex Group Ltd | 0.00% | New | 36,423 | $118K |
| XTX Topco Ltd | 0.00% | New | 24,006 | $78K |
| Arrowstreet Capital, Limited Partnership | 0.00% | New | 20,252 | $66K |
| Northern Trust Corp. | 0.00% | No change | 19,603 | $64K |
| Cresset Asset Management, LLC | 0.00% | Add +11.4% | 19,475 | $63K |
| Citadel Advisors | 0.00% | Reduce -24.2% | 16,643 | $54K |
| Jane Street Group, LLC | 0.00% | New | 14,607 | $47K |
| Two Sigma Investments, LP | 0.00% | Reduce -54.7% | 11,085 | $36K |
| UBS Group AG | 0.00% | Reduce -66.3% | 5,189 | $17K |
| Morgan Stanley | 0.00% | No change | 3,260 | $11K |
| Capital Advisors, Ltd. LLC | 0.00% | No change | 437 | $1K |
| Wells Fargo & Company | 0.00% | New | 100 | $325 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 2 | $6 |
| Huntington National Bank | 0.00% | No change | 1 | $3 |
| Royal Bank of Canada | 0.00% | New | 127 | $0 |
"% of holder's portfolio" is CPIX's weight in each manager's 13F, not the share of Cumberland Pharmaceuticals the manager owns.